US$ 26.90
bausch health companies inc glp-1 receptor agonist medications Shortage: Challenges and Solutions in Type 2 Diabetes Care Glaucoma Drug Fails Trial, But
Description
& Whiting, P

Nogueira, J

Hikma Pharmaceuticals Hikma is working on generic versions and biosimilars of GLP-1 drugs to improve accessibility and affordability in developing markets

This may be related to sympathetic activation by DPP4 inhibition (Packer, 2018)
